No Picture
Uncategorized

Global Market Development Manager, Flow Cytometry Instruments- Remote – Thermo Fisher Scientific – San Diego, CA

This experienced, dynamic manager will be a key member of the Protein and Cell Analysis Global Market Development team.From Thermo Fisher Scientific – Sat, 30 Oct 2021 08:23:07 GMT – View all San Diego, CA […]

No Picture
News

Oncternal Therapeutics to Provide Business Update and Report Third Quarter 2021 Financial Results

SAN DIEGO, Oct. 29, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report third quarter 2021 financial results after the U.S. financial markets close on Thursday, November 4, 2021. Oncternal’s management will host a… Click here to view original post… […]

No Picture
News

Uncovering how injury to the pancreas impacts cancer formation

LA JOLLA—Scientists at the Salk Institute and Vanderbilt University School of Medicine Basic Sciences have found that cells in the pancreas form new cell types to mitigate injury, but are then susceptible to cancerous mutations. The research, led by Salk Professor Geoffrey Wahl and Vanderbilt Assistant Professor Kathy… Click here to view original post… […]

No Picture
News

Alnylam’s John Maraganore isn’t the only CEO to leave his post; CRISPR’s chief commercial officer takes the helm at a protein degradation player

John Maraganore The departure of a number of CEOs is the prevailing theme that kicks off this week’s installment: In a stunner, Alnylam CEO John Maraganore announced that Yvonne Greenstreet will be his successor at the end of the year. Maraganore, the Cambridge, MA biotech’s… Click here to view original post… […]

No Picture
Uncategorized

Upstream Research Associate/Senior Research Associate – Cellics Therapeutics Inc. – San Diego, CA

Cellics Therapeutics is seeking an Upstream Research Associate/Senior Research Associate to perform cell culture and support various activities of upstream…From Indeed – Fri, 29 Oct 2021 04:19:11 GMT – View all San Diego, CA jobsClick […]

No Picture
Uncategorized

Research Assistant II, Plant Biology Laboratory – Dr. Joanne Chory – The Salk Institute for Biological Studies – La Jolla, CA

The CRoPS project aims to develop crop plants with enhanced root systems to sequester more carbon underground to fight climate change.From Indeed – Thu, 28 Oct 2021 21:58:36 GMT – View all La Jolla, CA […]

No Picture
Uncategorized

Research Assistant II – Molecular and Cell Biology Laboratory, Dr. Christia – The Salk Institute for Biological Studies – La Jolla, CA

The successful candidate will use engineered cells, animal models, and mass spectrometry to advance our studies in these areas.From Indeed – Thu, 28 Oct 2021 21:26:36 GMT – View all La Jolla, CA jobsClick here […]

No Picture
News

Salk Professor Tatyana Sharpee receives ASBMB DeLano Award

LA JOLLA—Salk Professor Tatyana Sharpee has won the American Society for Biochemistry and Molecular Biology’s (ASBMB) 2022 DeLano Award for Computational Biosciences. The award is given to a scientist with an innovative development or application of a computer technology that can enhance research in the life sciences… Click here to view original post… […]

No Picture
News

Long-lived proteins in mitochondria of brain stabilize protein complexes

LA JOLLA—Mitochondria are known as the powerhouses of the cell, generating the energy that’s needed to fuel the functions that our cells carry out. Now, scientists at the Salk Institute and the University of California San Diego (UCSD) have taken a closer look at how mitochondria are maintained in nondividing… Click here to view original post… […]

No Picture
News

Heron Therapeutics to Report Third Quarter 2021 Financial Results on Wednesday, November 3, 2021

SAN DIEGO: SAN DIEGO, Oct. 28, 2021 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that the company will host a conference call and… Click here to view original post… […]

No Picture
News

Inhibrx Strengthens Leadership Team with Three Key Executive Hires and Announces Appointment of Kristiina Vuori, M.D., Ph.D. to its Board of Directors

SAN DIEGO: SAN DIEGO, Oct. 28, 2021 /PRNewswire/ — Inhibrx, Inc. (Nasdaq: INBX), announced the appointment of three key executives: David Matly, M.B.A., as Chief Commercial Officer; David Kao, PharmD, M.B.A., RPh, as Vice President of Regulatory Affairs; and Jack Tsai, M.D., M.B.A., as Vice President of Business Development. "The… Click here to view original post… […]

No Picture
News

Roswell Biotechnologies Forms Scientific Advisory Board

SAN DIEGO: SAN DIEGO, Oct. 28, 2021 /PRNewswire/ — Roswell Biotechnologies, Inc., the molecular electronics company, announced today the formation of its Scientific Advisory Board (SAB). Comprised of industry and academic leaders in science and technology, the new SAB will be instrumental in the final stages of development and commercialization… Click here to view original post… […]

No Picture
News

A pair of partners at Frazier is following early-stage biotechs to the public market with an $830M fund. And they’re already doing deals

Just a few days ago, the executive team at San Diego-based Crinetics $CRNX announced that it is spawning a newborn biotech which 5AM helped to create along with Frazier Healthcare Partners, helping it get launched with a tidy, $30 million bankroll. Two… Click here to view original post… […]

No Picture
News

BioTheryX Announces Appointment of Philippe Drouet as Chief Executive Officer

SAN DIEGO: SAN DIEGO, Oct. 28, 2021 /PRNewswire/ — BioTheryX, Inc., a clinical-stage company focused on targeted protein degradation to create life-saving medicines, today announced the appointment of Philippe Drouet as President and Chief Executive Officer of BioTheryX. "Philippe is an extremely talented biopharma executive with more than two decades… Click here to view original post… […]

No Picture
News

Evofem Biosciences to Report Third Quarter 2021 Results and Provide Corporate Update on Monday, November 15, 2021

SAN DIEGO: SAN DIEGO, Oct. 28, 2021 /PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM) will hold a webcast and conference call to discuss financial results and business highlights for the third quarter ended September 30, 2021 on Monday, November 15, 2021 at 4:30 p.m. ET (1:30 p.m. PT). The webcast… Click here to view original post… […]

No Picture
News

HUYABIO Announces FDA Clearance to Initiate a Phase 1 Trial of SHP2 Inhibitor in Patients with KRAS and EGFR Mutated Tumors

SAN DIEGO: SAN DIEGO, Oct. 28, 2021 /PRNewswire/ — HUYABIO International (HUYABIO™), the leader in accelerating global development of China’s pharmaceutical innovations, announced today the FDA clearance of HBI-2376 as an Investigational New Drug, or IND, for a Phase 1 study. The authorization to proceed enables the first testing in… Click here to view original post… […]